Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

Oral Carbohydrate (CHO) Administration for Hypoglycemia Prevention and Treatment

The intervention in the REMODAL trial involves administering specific amounts of oral carbohydrates (CHO) at different glucose thresholds to evaluate the effectiveness of proactive versus reactive hypoglycemia management strategies in adults with Type 1 diabetes using continuous glucose monitoring (CGM). Participants will undergo three distinct interventions, each designed to test a different amount and timing of CHO intake.

Trial Locations (2)

H2W 1R7

RECRUITING

Institut de recherches cliniques de Montréal, Montreal

H2W1R7

RECRUITING

Montreal Clinical Research Institute, Montreal

All Listed Sponsors
lead

Institut de Recherches Cliniques de Montreal

OTHER